![Darren Cline](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darren Cline
Director/Board Member at
PYXIS ONCOLOGY, INC.
Net worth: 666 223 $ as of 2026-07-30
Profile
Mr. Darren S.
Cline is a Chief Commercial Officer at Xenon Pharmaceuticals, Inc., an Independent Director at Pliant Therapeutics, Inc. and an Independent Director at Pyxis Oncology, Inc. He is on the Board of Directors at Pliant Therapeutics, Inc. and Pyxis Oncology, Inc. Mr. Cline was previously employed as an Independent Director by IPI Legacy Liquidation Co., a President, Chief Executive Officer & Director by Epygenix Therapeutics, Inc., a Chief Commercial Officer by Greenwich Biosciences, Inc., a Chief Commercial Officer-United States by GW Pharmaceuticals Ltd., an Executive Vice President-Commercial by Seattle Genetics, Inc., a Vice President-Market Access by InterMune, Inc., an Executive Director-Sales by Alexion Pharmaceuticals, Inc., and a Marketing Director by Amgen, Inc. He also served on the board at Stemline Therapeutics, Inc., Cascadian Therapeutics LLC and Acadia Realty Trust.
He received his undergraduate degree from San Diego State University and an MBA from Pepperdine Graziadio Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 251,405 ( 0.4% ) | 666 223 $ | 2026-07-30 | |
| 2026-06-10 | 0 ( -.--% ) | - $ | 2026-07-30 | |
| 2026-01-08 | 0 ( -.--% ) | - $ | 2026-07-30 |
Darren Cline active positions
| Companies | Position | Start |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Director/Board Member | 2021-08-31 |
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 2023-03-05 |
| XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 2025-06-22 |
Former positions of Darren Cline
| Companies | Position | End |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Director/Board Member | 2024-03-31 |
Epygenix Therapeutics, Inc.
 Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Chief Executive Officer | 2023-02-28 |
Greenwich Biosciences, Inc.
 Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets cannabinoid prescription medicines through online | Corporate Officer/Principal | 2021-11-30 |
| GW PHARMACEUTICALS PLC | Corporate Officer/Principal | 2021-11-30 |
| SEAGEN INC. | Corporate Officer/Principal | 2019-02-28 |
Training of Darren Cline
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acadia Realty Trust
 Acadia Realty Trust Real Estate Investment TrustsFinance Operates as a real estate investment trust which owns, acquires, develops and manages retail properties | Finance |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Greenwich Biosciences, Inc.
Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets cannabinoid prescription medicines through online | Health Technology |
Pepperdine Graziadio Business School
 Pepperdine Graziadio Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
- Stock Market
- Insiders
- Darren Cline
